title: Omega-3 fatty acids and dementia.
abstract: More than a dozen epidemiological studies have reported that reduced levels or intake of omega-3 fatty acids or fish consumption is associated with increased risk for age-related cognitive decline or dementia such as Alzheimer's disease (AD). Increased dietary consumption or blood levels of docosahexaenoic acid (DHA) appear protective for AD and other dementia in multiple epidemiological studies; however, three studies suggest that the ApoE4 genotype limits protection. DHA is broadly neuroprotective via multiple mechanisms that include neuroprotective DHA metabolites, reduced arachidonic acid metabolites, and increased trophic factors or downstream trophic signal transduction. DHA is also protective against several risk factors for dementia including head trauma, diabetes, and cardiovascular disease. DHA is specifically protective against AD via additional mechanisms: It limits the production and accumulation of the amyloid beta peptide toxin that is widely believed to drive the disease; and it also suppresses several signal transduction pathways induced by Abeta, including two major kinases that phosphorylate the microtubule-associated protein tau and promote neurofibrillary tangle pathology. Based on the epidemiological and basic research data, expert panels have recommended the need for clinical trials with omega-3 fatty acids, notably DHA, for the prevention or treatment of age-related cognitive decline--with a focus on the most prevalent cause, AD. Clinical trials are underway to prevent and treat AD. Results to-date suggest that DHA may be more effective if it is begun early or used in conjunction with antioxidants.
authors.affiliation: Department of Medicine at University of California, Los Angeles, CA, USA. gmcole@ucla.edu
authors.forename: Greg M
authors.initials: GM
authors.lastname: Cole
authors.forename: Qiu-Lan
authors.initials: QL
authors.lastname: Ma
authors.forename: Sally A
authors.initials: SA
authors.lastname: Frautschy
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000188:drug therapy; D000818:Animals; D000975:Antioxidants / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003072:Cognition Disorders / Q000517:prevention & control; D003704:Dementia / Q000188:drug therapy / Q000517:prevention & control; D004032:Diet; D015525:Fatty Acids, Omega-3 / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D018696:Neuroprotective Agents / Q000627:therapeutic use; D012306:Risk; D016875:tau Proteins / Q000037:antagonists & inhibitors
chemical_list: D000975:Antioxidants; D015525:Fatty Acids, Omega-3; D018696:Neuroprotective Agents; D016875:tau Proteins